Baseline patient characteristics between respiratory muscle weakness with and without frailty
. | Overall . | Non-frail . | . | Frail . | . | ||
---|---|---|---|---|---|---|---|
. | (n = 1217) . | (n = 922) . | . | (n = 295) . | . | ||
. | . | RMW (−) . | RMW (+) . | P-value . | RMW (−) . | RMW (+) . | P-value . |
. | . | (n = 615) . | (n = 307) . | . | (n = 146) . | (n = 149) . | . |
Age | 69 ± 14 | 67 ± 13 | 71 ± 14 | <0.001 | 73 ± 13 | 73 ± 14 | 0.758 |
Sex, n (%) | |||||||
Female | 380 (31.2) | 193 (31.4) | 95 (30.9) | 0.940 | 42 (28.8) | 50 (33.6) | 0.382 |
Male | 837 (68.8) | 422 (68.6) | 212 (69.1) | 104 (71.2) | 99 (66.4) | ||
Heart rate, beat/min | 77 ± 20 | 77 ± 22 | 76 ± 17 | 0.457 | 79 ± 20 | 79 ± 19 | 0.861 |
sBP, mmHg | 115 ± 19 | 115 ± 19 | 116 ± 19 | 0.305 | 113 ± 20 | 114 ± 20 | 0.627 |
dBP, mmHg | 67 ± 13 | 68 ± 13 | 67 ± 14 | 0.238 | 67 ± 12 | 66 ± 13 | 0.673 |
BMI, kg/m2 | 22.6 ± 3.9 | 23.2 ± 3.6 | 22.8 ± 4.2 | 0.186 | 21.2 ± 3.8 | 21.1 ± 3.9 | 0.791 |
Cause of admission, n (%) | |||||||
ACS | 300 (24.7) | 190 (30.9) | 68 (22.1) | 0.005 | 16 (11.0) | 26 (17.4) | 0.134 |
Heart failure | 685 (56.3) | 296 (48.1) | 186 (60.6) | <0.001 | 98 (67.1) | 105 (70.5) | 0.615 |
Current smoker, n (%) | 267 (22.2) | 151 (24.9) | 50 (16.5) | 0.004 | 35 (24.1) | 31 (21.1) | 0.577 |
Comorbidities, n (%) | |||||||
Hypertension | 751 (61.7) | 383 (62.3) | 191 (62.2) | 1.000 | 82 (56.2) | 95 (63.8) | 0.193 |
Dyslipidaemia | 488 (40.1) | 276 (44.9) | 110 (35.8) | 0.009 | 44 (30.1) | 58 (38.9) | 0.142 |
Diabetes mellitus | 399 (32.8) | 198 (32.2) | 87 (28.3) | 0.257 | 51 (34.9) | 63 (42.3) | 0.232 |
Ischaemic heart disease | 227 (18.7) | 107 (17.4) | 63 (20.5) | 0.280 | 28 (19.2) | 29 (19.5) | 1.000 |
Atrial fibrillation | 313 (25.7) | 134 (21.8) | 88 (28.7) | 0.022 | 51 (34.9) | 40 (26.8) | 0.086 |
Chronic kidney disease | 821 (67.5) | 380 (61.8) | 229 (74.6) | <0.001 | 108 (74.0) | 104 (69.8) | 0.440 |
Medications, n (%) | |||||||
ACE-I or ARB | 932 (76.6) | 469 (76.3) | 239 (77.9) | 0.620 | 109 (74.7) | 115 (77.2) | 0.683 |
Beta-blockers | 878 (72.1) | 446 (72.5) | 220 (71.7) | 0.815 | 102 (69.9) | 110 (73.8) | 0.518 |
Diuretics | 859 (70.6) | 405 (65.9) | 220 (71.7) | 0.085 | 115 (78.8) | 119 (79.9) | 0.886 |
Loop diuretics | 395 (32.5) | 170 (27.6) | 114 (37.1) | 0.004 | 52 (35.6) | 59 (39.6) | 0.548 |
MRA | 381 (31.3) | 177 (28.8) | 97 (31.6) | 0.401 | 52 (35.6) | 55 (36.9) | 0.904 |
Statin | 667 (54.8) | 354 (57.6) | 166 (54.1) | 0.324 | 71 (48.6) | 76 (51.0) | 0.727 |
LVEF, % | 50.9 ± 16.9 | 51.4 ± 16.0 | 51.2 ± 16.7 | 0.832 | 49.9 ± 19.0 | 49.3 ± 19.1 | 0.788 |
Haemoglobin, g/dL | 12.4 ± 2.2 | 12.8 ± 2.1 | 12.1 ± 2.2 | <0.001 | 12.0 ± 2.2 | 11.7 ± 2.2 | 0.290 |
Albumin, g/dL | 3.6 ± 0.6 | 3.8 ± 0.6 | 3.7 ± 0.5 | 0.019 | 3.5 ± 0.6 | 3.3 ± 0.6 | 0.063 |
BUN, mg/dL | 19.0 (14.3–26.2) | 17.8 (13.9–23.6) | 18.3 (14.1–25.9) | 0.121 | 21.8 (16.1–30.2) | 23.3 (17.1–31.6) | 0.277 |
Creatinine, mg/dL | 1.03 (0.83–1.36) | 1.01 (0.82–1.29) | 1.06 (0.86–1.39) | 0.011 | 1.09 (0.87–1.50) | 1.16 (0.84–1.68) | 0.422 |
eGFR, mL/min/1.73 m2 | 50.0 (35.5–65.0) | 55.0 (40.5–66.0) | 47.0 (34.0–63.0) | <0.001 | 49.0 (29.0–64.0) | 45.0 (28.0–64.0) | 0.692 |
CRP, mg/dL | 0.42 (0.13–1.36) | 0.40 (0.12–1.25) | 0.36 (0.13–1.49) | 0.607 | 0.57 (0.13–1.68) | 0.54 (0.26–1.44) | 0.616 |
BNP, pg/mL | 317.0 (91.6–794.0) | 231.4 (51.8–632.2) | 393.1 (113.0–937.8) | <0.001 | 413.1 (184.5–894.9) | 475.0 (164.5–1051.6) | 0.515 |
. | Overall . | Non-frail . | . | Frail . | . | ||
---|---|---|---|---|---|---|---|
. | (n = 1217) . | (n = 922) . | . | (n = 295) . | . | ||
. | . | RMW (−) . | RMW (+) . | P-value . | RMW (−) . | RMW (+) . | P-value . |
. | . | (n = 615) . | (n = 307) . | . | (n = 146) . | (n = 149) . | . |
Age | 69 ± 14 | 67 ± 13 | 71 ± 14 | <0.001 | 73 ± 13 | 73 ± 14 | 0.758 |
Sex, n (%) | |||||||
Female | 380 (31.2) | 193 (31.4) | 95 (30.9) | 0.940 | 42 (28.8) | 50 (33.6) | 0.382 |
Male | 837 (68.8) | 422 (68.6) | 212 (69.1) | 104 (71.2) | 99 (66.4) | ||
Heart rate, beat/min | 77 ± 20 | 77 ± 22 | 76 ± 17 | 0.457 | 79 ± 20 | 79 ± 19 | 0.861 |
sBP, mmHg | 115 ± 19 | 115 ± 19 | 116 ± 19 | 0.305 | 113 ± 20 | 114 ± 20 | 0.627 |
dBP, mmHg | 67 ± 13 | 68 ± 13 | 67 ± 14 | 0.238 | 67 ± 12 | 66 ± 13 | 0.673 |
BMI, kg/m2 | 22.6 ± 3.9 | 23.2 ± 3.6 | 22.8 ± 4.2 | 0.186 | 21.2 ± 3.8 | 21.1 ± 3.9 | 0.791 |
Cause of admission, n (%) | |||||||
ACS | 300 (24.7) | 190 (30.9) | 68 (22.1) | 0.005 | 16 (11.0) | 26 (17.4) | 0.134 |
Heart failure | 685 (56.3) | 296 (48.1) | 186 (60.6) | <0.001 | 98 (67.1) | 105 (70.5) | 0.615 |
Current smoker, n (%) | 267 (22.2) | 151 (24.9) | 50 (16.5) | 0.004 | 35 (24.1) | 31 (21.1) | 0.577 |
Comorbidities, n (%) | |||||||
Hypertension | 751 (61.7) | 383 (62.3) | 191 (62.2) | 1.000 | 82 (56.2) | 95 (63.8) | 0.193 |
Dyslipidaemia | 488 (40.1) | 276 (44.9) | 110 (35.8) | 0.009 | 44 (30.1) | 58 (38.9) | 0.142 |
Diabetes mellitus | 399 (32.8) | 198 (32.2) | 87 (28.3) | 0.257 | 51 (34.9) | 63 (42.3) | 0.232 |
Ischaemic heart disease | 227 (18.7) | 107 (17.4) | 63 (20.5) | 0.280 | 28 (19.2) | 29 (19.5) | 1.000 |
Atrial fibrillation | 313 (25.7) | 134 (21.8) | 88 (28.7) | 0.022 | 51 (34.9) | 40 (26.8) | 0.086 |
Chronic kidney disease | 821 (67.5) | 380 (61.8) | 229 (74.6) | <0.001 | 108 (74.0) | 104 (69.8) | 0.440 |
Medications, n (%) | |||||||
ACE-I or ARB | 932 (76.6) | 469 (76.3) | 239 (77.9) | 0.620 | 109 (74.7) | 115 (77.2) | 0.683 |
Beta-blockers | 878 (72.1) | 446 (72.5) | 220 (71.7) | 0.815 | 102 (69.9) | 110 (73.8) | 0.518 |
Diuretics | 859 (70.6) | 405 (65.9) | 220 (71.7) | 0.085 | 115 (78.8) | 119 (79.9) | 0.886 |
Loop diuretics | 395 (32.5) | 170 (27.6) | 114 (37.1) | 0.004 | 52 (35.6) | 59 (39.6) | 0.548 |
MRA | 381 (31.3) | 177 (28.8) | 97 (31.6) | 0.401 | 52 (35.6) | 55 (36.9) | 0.904 |
Statin | 667 (54.8) | 354 (57.6) | 166 (54.1) | 0.324 | 71 (48.6) | 76 (51.0) | 0.727 |
LVEF, % | 50.9 ± 16.9 | 51.4 ± 16.0 | 51.2 ± 16.7 | 0.832 | 49.9 ± 19.0 | 49.3 ± 19.1 | 0.788 |
Haemoglobin, g/dL | 12.4 ± 2.2 | 12.8 ± 2.1 | 12.1 ± 2.2 | <0.001 | 12.0 ± 2.2 | 11.7 ± 2.2 | 0.290 |
Albumin, g/dL | 3.6 ± 0.6 | 3.8 ± 0.6 | 3.7 ± 0.5 | 0.019 | 3.5 ± 0.6 | 3.3 ± 0.6 | 0.063 |
BUN, mg/dL | 19.0 (14.3–26.2) | 17.8 (13.9–23.6) | 18.3 (14.1–25.9) | 0.121 | 21.8 (16.1–30.2) | 23.3 (17.1–31.6) | 0.277 |
Creatinine, mg/dL | 1.03 (0.83–1.36) | 1.01 (0.82–1.29) | 1.06 (0.86–1.39) | 0.011 | 1.09 (0.87–1.50) | 1.16 (0.84–1.68) | 0.422 |
eGFR, mL/min/1.73 m2 | 50.0 (35.5–65.0) | 55.0 (40.5–66.0) | 47.0 (34.0–63.0) | <0.001 | 49.0 (29.0–64.0) | 45.0 (28.0–64.0) | 0.692 |
CRP, mg/dL | 0.42 (0.13–1.36) | 0.40 (0.12–1.25) | 0.36 (0.13–1.49) | 0.607 | 0.57 (0.13–1.68) | 0.54 (0.26–1.44) | 0.616 |
BNP, pg/mL | 317.0 (91.6–794.0) | 231.4 (51.8–632.2) | 393.1 (113.0–937.8) | <0.001 | 413.1 (184.5–894.9) | 475.0 (164.5–1051.6) | 0.515 |
Values are mean ± SD, or median (interquartile range).
ACE-I, angiotensin-convertor enzyme inhibitor; ACS, acute coronary syndrome; ARB, angiotensin II receptor blocker; BMI, body mass index; BNP, brain natriuretic peptide; BUN, blood urea nitrogen; CRP, C-reactive protein; dBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; MRA, mineralocorticoid receptor antagonist; RMW, respiratory muscle weakness; sBP, systolic blood pressure.
Baseline patient characteristics between respiratory muscle weakness with and without frailty
. | Overall . | Non-frail . | . | Frail . | . | ||
---|---|---|---|---|---|---|---|
. | (n = 1217) . | (n = 922) . | . | (n = 295) . | . | ||
. | . | RMW (−) . | RMW (+) . | P-value . | RMW (−) . | RMW (+) . | P-value . |
. | . | (n = 615) . | (n = 307) . | . | (n = 146) . | (n = 149) . | . |
Age | 69 ± 14 | 67 ± 13 | 71 ± 14 | <0.001 | 73 ± 13 | 73 ± 14 | 0.758 |
Sex, n (%) | |||||||
Female | 380 (31.2) | 193 (31.4) | 95 (30.9) | 0.940 | 42 (28.8) | 50 (33.6) | 0.382 |
Male | 837 (68.8) | 422 (68.6) | 212 (69.1) | 104 (71.2) | 99 (66.4) | ||
Heart rate, beat/min | 77 ± 20 | 77 ± 22 | 76 ± 17 | 0.457 | 79 ± 20 | 79 ± 19 | 0.861 |
sBP, mmHg | 115 ± 19 | 115 ± 19 | 116 ± 19 | 0.305 | 113 ± 20 | 114 ± 20 | 0.627 |
dBP, mmHg | 67 ± 13 | 68 ± 13 | 67 ± 14 | 0.238 | 67 ± 12 | 66 ± 13 | 0.673 |
BMI, kg/m2 | 22.6 ± 3.9 | 23.2 ± 3.6 | 22.8 ± 4.2 | 0.186 | 21.2 ± 3.8 | 21.1 ± 3.9 | 0.791 |
Cause of admission, n (%) | |||||||
ACS | 300 (24.7) | 190 (30.9) | 68 (22.1) | 0.005 | 16 (11.0) | 26 (17.4) | 0.134 |
Heart failure | 685 (56.3) | 296 (48.1) | 186 (60.6) | <0.001 | 98 (67.1) | 105 (70.5) | 0.615 |
Current smoker, n (%) | 267 (22.2) | 151 (24.9) | 50 (16.5) | 0.004 | 35 (24.1) | 31 (21.1) | 0.577 |
Comorbidities, n (%) | |||||||
Hypertension | 751 (61.7) | 383 (62.3) | 191 (62.2) | 1.000 | 82 (56.2) | 95 (63.8) | 0.193 |
Dyslipidaemia | 488 (40.1) | 276 (44.9) | 110 (35.8) | 0.009 | 44 (30.1) | 58 (38.9) | 0.142 |
Diabetes mellitus | 399 (32.8) | 198 (32.2) | 87 (28.3) | 0.257 | 51 (34.9) | 63 (42.3) | 0.232 |
Ischaemic heart disease | 227 (18.7) | 107 (17.4) | 63 (20.5) | 0.280 | 28 (19.2) | 29 (19.5) | 1.000 |
Atrial fibrillation | 313 (25.7) | 134 (21.8) | 88 (28.7) | 0.022 | 51 (34.9) | 40 (26.8) | 0.086 |
Chronic kidney disease | 821 (67.5) | 380 (61.8) | 229 (74.6) | <0.001 | 108 (74.0) | 104 (69.8) | 0.440 |
Medications, n (%) | |||||||
ACE-I or ARB | 932 (76.6) | 469 (76.3) | 239 (77.9) | 0.620 | 109 (74.7) | 115 (77.2) | 0.683 |
Beta-blockers | 878 (72.1) | 446 (72.5) | 220 (71.7) | 0.815 | 102 (69.9) | 110 (73.8) | 0.518 |
Diuretics | 859 (70.6) | 405 (65.9) | 220 (71.7) | 0.085 | 115 (78.8) | 119 (79.9) | 0.886 |
Loop diuretics | 395 (32.5) | 170 (27.6) | 114 (37.1) | 0.004 | 52 (35.6) | 59 (39.6) | 0.548 |
MRA | 381 (31.3) | 177 (28.8) | 97 (31.6) | 0.401 | 52 (35.6) | 55 (36.9) | 0.904 |
Statin | 667 (54.8) | 354 (57.6) | 166 (54.1) | 0.324 | 71 (48.6) | 76 (51.0) | 0.727 |
LVEF, % | 50.9 ± 16.9 | 51.4 ± 16.0 | 51.2 ± 16.7 | 0.832 | 49.9 ± 19.0 | 49.3 ± 19.1 | 0.788 |
Haemoglobin, g/dL | 12.4 ± 2.2 | 12.8 ± 2.1 | 12.1 ± 2.2 | <0.001 | 12.0 ± 2.2 | 11.7 ± 2.2 | 0.290 |
Albumin, g/dL | 3.6 ± 0.6 | 3.8 ± 0.6 | 3.7 ± 0.5 | 0.019 | 3.5 ± 0.6 | 3.3 ± 0.6 | 0.063 |
BUN, mg/dL | 19.0 (14.3–26.2) | 17.8 (13.9–23.6) | 18.3 (14.1–25.9) | 0.121 | 21.8 (16.1–30.2) | 23.3 (17.1–31.6) | 0.277 |
Creatinine, mg/dL | 1.03 (0.83–1.36) | 1.01 (0.82–1.29) | 1.06 (0.86–1.39) | 0.011 | 1.09 (0.87–1.50) | 1.16 (0.84–1.68) | 0.422 |
eGFR, mL/min/1.73 m2 | 50.0 (35.5–65.0) | 55.0 (40.5–66.0) | 47.0 (34.0–63.0) | <0.001 | 49.0 (29.0–64.0) | 45.0 (28.0–64.0) | 0.692 |
CRP, mg/dL | 0.42 (0.13–1.36) | 0.40 (0.12–1.25) | 0.36 (0.13–1.49) | 0.607 | 0.57 (0.13–1.68) | 0.54 (0.26–1.44) | 0.616 |
BNP, pg/mL | 317.0 (91.6–794.0) | 231.4 (51.8–632.2) | 393.1 (113.0–937.8) | <0.001 | 413.1 (184.5–894.9) | 475.0 (164.5–1051.6) | 0.515 |
. | Overall . | Non-frail . | . | Frail . | . | ||
---|---|---|---|---|---|---|---|
. | (n = 1217) . | (n = 922) . | . | (n = 295) . | . | ||
. | . | RMW (−) . | RMW (+) . | P-value . | RMW (−) . | RMW (+) . | P-value . |
. | . | (n = 615) . | (n = 307) . | . | (n = 146) . | (n = 149) . | . |
Age | 69 ± 14 | 67 ± 13 | 71 ± 14 | <0.001 | 73 ± 13 | 73 ± 14 | 0.758 |
Sex, n (%) | |||||||
Female | 380 (31.2) | 193 (31.4) | 95 (30.9) | 0.940 | 42 (28.8) | 50 (33.6) | 0.382 |
Male | 837 (68.8) | 422 (68.6) | 212 (69.1) | 104 (71.2) | 99 (66.4) | ||
Heart rate, beat/min | 77 ± 20 | 77 ± 22 | 76 ± 17 | 0.457 | 79 ± 20 | 79 ± 19 | 0.861 |
sBP, mmHg | 115 ± 19 | 115 ± 19 | 116 ± 19 | 0.305 | 113 ± 20 | 114 ± 20 | 0.627 |
dBP, mmHg | 67 ± 13 | 68 ± 13 | 67 ± 14 | 0.238 | 67 ± 12 | 66 ± 13 | 0.673 |
BMI, kg/m2 | 22.6 ± 3.9 | 23.2 ± 3.6 | 22.8 ± 4.2 | 0.186 | 21.2 ± 3.8 | 21.1 ± 3.9 | 0.791 |
Cause of admission, n (%) | |||||||
ACS | 300 (24.7) | 190 (30.9) | 68 (22.1) | 0.005 | 16 (11.0) | 26 (17.4) | 0.134 |
Heart failure | 685 (56.3) | 296 (48.1) | 186 (60.6) | <0.001 | 98 (67.1) | 105 (70.5) | 0.615 |
Current smoker, n (%) | 267 (22.2) | 151 (24.9) | 50 (16.5) | 0.004 | 35 (24.1) | 31 (21.1) | 0.577 |
Comorbidities, n (%) | |||||||
Hypertension | 751 (61.7) | 383 (62.3) | 191 (62.2) | 1.000 | 82 (56.2) | 95 (63.8) | 0.193 |
Dyslipidaemia | 488 (40.1) | 276 (44.9) | 110 (35.8) | 0.009 | 44 (30.1) | 58 (38.9) | 0.142 |
Diabetes mellitus | 399 (32.8) | 198 (32.2) | 87 (28.3) | 0.257 | 51 (34.9) | 63 (42.3) | 0.232 |
Ischaemic heart disease | 227 (18.7) | 107 (17.4) | 63 (20.5) | 0.280 | 28 (19.2) | 29 (19.5) | 1.000 |
Atrial fibrillation | 313 (25.7) | 134 (21.8) | 88 (28.7) | 0.022 | 51 (34.9) | 40 (26.8) | 0.086 |
Chronic kidney disease | 821 (67.5) | 380 (61.8) | 229 (74.6) | <0.001 | 108 (74.0) | 104 (69.8) | 0.440 |
Medications, n (%) | |||||||
ACE-I or ARB | 932 (76.6) | 469 (76.3) | 239 (77.9) | 0.620 | 109 (74.7) | 115 (77.2) | 0.683 |
Beta-blockers | 878 (72.1) | 446 (72.5) | 220 (71.7) | 0.815 | 102 (69.9) | 110 (73.8) | 0.518 |
Diuretics | 859 (70.6) | 405 (65.9) | 220 (71.7) | 0.085 | 115 (78.8) | 119 (79.9) | 0.886 |
Loop diuretics | 395 (32.5) | 170 (27.6) | 114 (37.1) | 0.004 | 52 (35.6) | 59 (39.6) | 0.548 |
MRA | 381 (31.3) | 177 (28.8) | 97 (31.6) | 0.401 | 52 (35.6) | 55 (36.9) | 0.904 |
Statin | 667 (54.8) | 354 (57.6) | 166 (54.1) | 0.324 | 71 (48.6) | 76 (51.0) | 0.727 |
LVEF, % | 50.9 ± 16.9 | 51.4 ± 16.0 | 51.2 ± 16.7 | 0.832 | 49.9 ± 19.0 | 49.3 ± 19.1 | 0.788 |
Haemoglobin, g/dL | 12.4 ± 2.2 | 12.8 ± 2.1 | 12.1 ± 2.2 | <0.001 | 12.0 ± 2.2 | 11.7 ± 2.2 | 0.290 |
Albumin, g/dL | 3.6 ± 0.6 | 3.8 ± 0.6 | 3.7 ± 0.5 | 0.019 | 3.5 ± 0.6 | 3.3 ± 0.6 | 0.063 |
BUN, mg/dL | 19.0 (14.3–26.2) | 17.8 (13.9–23.6) | 18.3 (14.1–25.9) | 0.121 | 21.8 (16.1–30.2) | 23.3 (17.1–31.6) | 0.277 |
Creatinine, mg/dL | 1.03 (0.83–1.36) | 1.01 (0.82–1.29) | 1.06 (0.86–1.39) | 0.011 | 1.09 (0.87–1.50) | 1.16 (0.84–1.68) | 0.422 |
eGFR, mL/min/1.73 m2 | 50.0 (35.5–65.0) | 55.0 (40.5–66.0) | 47.0 (34.0–63.0) | <0.001 | 49.0 (29.0–64.0) | 45.0 (28.0–64.0) | 0.692 |
CRP, mg/dL | 0.42 (0.13–1.36) | 0.40 (0.12–1.25) | 0.36 (0.13–1.49) | 0.607 | 0.57 (0.13–1.68) | 0.54 (0.26–1.44) | 0.616 |
BNP, pg/mL | 317.0 (91.6–794.0) | 231.4 (51.8–632.2) | 393.1 (113.0–937.8) | <0.001 | 413.1 (184.5–894.9) | 475.0 (164.5–1051.6) | 0.515 |
Values are mean ± SD, or median (interquartile range).
ACE-I, angiotensin-convertor enzyme inhibitor; ACS, acute coronary syndrome; ARB, angiotensin II receptor blocker; BMI, body mass index; BNP, brain natriuretic peptide; BUN, blood urea nitrogen; CRP, C-reactive protein; dBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; MRA, mineralocorticoid receptor antagonist; RMW, respiratory muscle weakness; sBP, systolic blood pressure.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.